11/07/2017 - 3:53pm
Diplomat’s CEO and chairman, Phil Hagerman, said the acquisition of National Pharmaceutical Services is a way of responding to patient and employer demands for flexible methods aimed at improving outcomes and reduced costs.
11/07/2017 - 11:40am

This acquisition will enhance McKesson’s commercialization solutions for manufacturers of branded, specialty, generic and biosimilar drugs, including comprehensive patient support, or “hub,” services.

11/02/2017 - 4:00pm
The mantle cell lymphoma treatment is set to be dispensed by a limited group of specialty pharmacies, which include Diplomat Pharmacy and Avella Specialty Pharmacy.
10/31/2017 - 1:01pm

Diplomat Pharmacy has a new member of its executive leadership team who brings with her more than a quarter-century of industry experience.

10/19/2017 - 2:14pm

Yescarta, from Gilead’s recently acquired company Kite, was approved to treat relapsed or refractory large B-cell lymphoma following two or more lines of systemic therapy.

10/18/2017 - 4:51pm

As specialty growth looks set to plateau, the drug class continues to see its share of per-capita spending increase, with a decline in spending on traditional medicines creating space for more specialty share.

10/16/2017 - 2:54pm

According to the World Health Organization, roughly one-third of patients diagnosed with plaque psoriasis is younger than 20 years of age, and adolescents in particular have limited treatment options.

10/10/2017 - 3:20pm

The drug was approved to treat certain cases of advanced or metastatic breast cancer, either alone or in combination with Faslodex.

10/06/2017 - 11:50am

The newly re-launched product is Health Canada compliant and has been available for purchase online since Sept.  29.